VDAC2 loss elicits tumour destruction and inflammation for cancer therapy
www.nature.com
Nature, Published online: 19 March 2025; doi:10.1038/s41586-025-08732-6VDAC2 deficiency elicits uncontrolled IFN-induced BAK activation and mitochondrial damage for improved cancer therapy.
0 Reacties ·0 aandelen ·79 Views